In accordance with these reports, in our study increased cytochrome c release upon S100A11 silencing was abrogated by NAC, together with the abolishment of elevated O2−• production and chemosensitization, in NSCLC A549 cells treated with cisplatin (Fig. 6A). Here, S100A11 is linked to non-small cell lung carcinoma.